Antares Pharma Profit Margin

Antares Pharma's profit margin stands at 21.9% as of March 2022. That compares with 39.31% in the prior-year period — down 44.3% year over year. That is above the Healthcare sector average of 14.41%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Antares Pharma reported 21.9% in profit margin versus 39.31% a year earlier — a 44.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Antares Pharma sits higher the Healthcare benchmark (14.41%) with a profit margin of 21.9%. That is roughly 51.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 21.9% for Antares Pharma means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Antares Pharma's profit margin evolved across reporting periods, while the comparison chart places ATRS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.